SY JENNIFER (PRINCIPAL ACCOUNTING OFFICER) received a stock award from AEON BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/4/2024ACC: 0001104659-24-097062
Officer· PRINCIPAL ACCOUNTING OFFICER
Since Feb 2026
+66.07K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
66.07K acquired
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+18.01K
Price / share
—
Trade value
—
% of position
New position
8/31/2024
0.00→18.01K
Total
Net shares
+18.01K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 8/31/2024 | A · Award | +18.01K | — | — | New position | 0.00 | 18.01K |
| Total | +18.01K | $0.00 | ||||||
Derivative Transactions1
Stock Option
Direct
Converts to
Class A Common Stock
48.06K shares
Shares
+48.06K
Strike price
0.83
Held after
48.06K
Exercisable
—
8/31/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Direct | Class A Common Stock48.06K shares | 8/31/2024 | A · Award | +48.06K | 0.83 | — | 48.06K |